Peregrine Pharmaceuticals

NASDAQ: PPHM
$4.22
+$0.03 (+0.7%)
Closing Price on January 5, 2018

PPHM Chart and Intraday Price

PPHM Company Data

Asset Type ETF
Exchange NASDAQ
Sector Healthcare
Industry Drugs

PPHM Articles

December 30, 2016: Here are four stocks trading with relatively heavy volume among 66 equities making new 52-week lows in Friday’s session. On the NYSE, decliners led advancers by about 3 to 2...
Although stocks are beginning to make a comeback, there are still those that are caught in the downturn slowing this recovery.
Peregine Pharmaceuticals has announced that it is discontinuing its Phase 3 Sunrise trial of bavituximab in patients with previously treated locally advanced or metastatic non-squamous non-small cell...
Peregrine Pharmaceuticals may be on the verge of something big with its anticancer drugs. The shares soared almost 50% on Wednesday. It is working on developing drugs that can train the body's immune...
U.S. equity markets opened slightly lower this morning following on some poor data on eurozone industrial production, which fell more than expected. Non-farm payrolls fell more than expected in...
U.S. equity markets opened lower this morning but never managed to hold a position in positive territory. Despite a significant drop in U.K. industrial production in February, the country’s trade...
U.S. equity markets opened higher this morning following a closely watched report on U.S. retail sales came in about as expected (more coverage here). U.S. business inventories rose less than...
U.S. equity markets opened lower this morning as investors seem to have reined in the enthusiasm that kicked off the new year. There was little new data out today, so markets followed the news. In...
The stock market is down Monday, with the Dow Jones Industrial Average down 0.42%, the Nasdaq down 0.18% and the S&P 500 down 0.43%. Today’s winners include a pharmaceutical providing a...
Source: ThinkstockThere are big movers in the market just about every day, and these movers often come from biotech and other emerging health care winners and losers. The daily direction of the broad...
The three major U.S. stock indexes opened higher this morning as markets shook off weak news from Europe in favor of better news from Asia. In Europe, German unemployment stayed at 8.6% (more...
Source: Photo by Spencer Platt/Getty ImagesThe stock market rose Thursday early in trading, with the Dow Jones Industrial Average up 0.12%, the Nasdaq up 0.46% and the S&P 500 up 0.27%. Trading...
The stock market is down Wednesday, with the Dow Jones Industrial Average down 0.12%, the Nasdaq down 0.76% and the S&P 500 down 0.42%. Today’s only winner is a pharmaceutical company that has been...
The three major U.S. stock indexes opened higher this morning but were unable to hold gains into the afternoon. In Europe this morning, a Spanish bond auction widened the spread between German and...
Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) fell about 80% yesterday after the company revealed that there were discrepancies in the data reported on the company’s Phase II trial of its...